These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 18776548)

  • 1. In vitro activity and mechanism of action of a duplex and multidrug of ethynylcytidine and 5-fluorodeoxyuridine.
    Bijnsdorp IV; Schwendener RA; Schott H; Schott S; Fichtner I; Honeywell RJ; Losekoot N; Laan AC; Peters GJ
    Nucleic Acids Symp Ser (Oxf); 2008; (52):651. PubMed ID: 18776548
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and in vitro activities of new anticancer duplex drugs linking 2'-deoxy-5-fluorouridine (5-FdU) with 3'-C-ethynylcytidine (ECyd) via a phosphodiester bonding.
    Schott H; Schott S; Schwendener RA
    Bioorg Med Chem; 2009 Oct; 17(19):6824-31. PubMed ID: 19744858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity and antileukaemic activity of new duplexes linking 3-C-ethynylcytidine and 5-fluorodeoxyuridine.
    Novotny L; Rauko P; Schott H
    Anticancer Res; 2010 Dec; 30(12):4891-8. PubMed ID: 21187467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of gastric adenocarcinoma and normal cell lines against combined or conjugated antimetabolites.
    Weinreich J; Struller F; Küper M; Hack A; Königsrainer A; Schott TC
    Anticancer Drugs; 2013 Apr; 24(4):375-83. PubMed ID: 23358120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular pharmacology of multi- and duplex drugs consisting of ethynylcytidine and 5-fluoro-2'-deoxyuridine.
    Bijnsdorp IV; Schwendener RA; Schott H; Fichtner I; Smid K; Laan AC; Schott S; Losekoot N; Honeywell RJ; Peters GJ
    Invest New Drugs; 2011 Apr; 29(2):248-57. PubMed ID: 19957099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytostatic activity of the duplex drug linking 2'-deoxy-5-fluorouridine (5FdU) with 3'-C-ethynylcytidine (ECyd) against gastric adenocarcinoma cell lines.
    Weinreich J; Schott S; Königsrainer I; Zieker D; Königsrainer A; Schott H
    Invest New Drugs; 2011 Dec; 29(6):1294-302. PubMed ID: 20596746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterodinucleoside phosphates of 5-fluorodeoxyuridine and arabinofuranosylcytosine--new drugs in cancer chemotherapy?
    Saiko P; Horvath Z; Jaeger W; Schott H; Fritzer-Szekeres M; Szekeres T
    In Vivo; 2005; 19(1):205-14. PubMed ID: 15796176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-FdUrd-araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2.
    Strasser S; Maier S; Leisser C; Saiko P; Madlener S; Bader Y; Bernhaus A; Gueorguieva M; Richter S; Mader RM; Wesierska-Gadek J; Schott H; Szekeres T; Fritzer-Szekeres M; Krupitza G
    Differentiation; 2006 Dec; 74(9-10):488-98. PubMed ID: 17177846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of mechanisms contributing to AraC-mediated chemoresistance and re-establishment of drug sensitivity by the novel heterodinucleoside phosphate 5-FdUrd-araC.
    Maier S; Strasser S; Saiko P; Leisser C; Sasgary S; Grusch M; Madlener S; Bader Y; Hartmann J; Schott H; Mader RM; Szekeres T; Fritzer-Szekeres M; Krupitza G
    Apoptosis; 2006 Mar; 11(3):427-40. PubMed ID: 16538382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PK-PD modeling of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and the enhanced antitumor effect of its phospholipid derivatives in long-circulating liposomes.
    Takada A; Kamiya H; Shuto S; Matsuda A; Harashima H
    Int J Pharm; 2009 Jul; 377(1-2):52-9. PubMed ID: 19426792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106)1: antitumor effect and mechanism of action.
    Azuma A; Matsuda A; Sasaki T; Fukushima M
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):609-19. PubMed ID: 11563078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of new duplex drugs linking 3'-C-ethynylcytidine and 5-fluor-2'-deoxyuridine against human melanoma cells.
    Schott S; Niessner H; Sinnberg T; Venturelli S; Berger A; Ikenberg K; Villanueva J; Meier F; Garbe C; Busch C
    Int J Cancer; 2012 Nov; 131(9):2165-74. PubMed ID: 22323315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleosides and nucleotides. 180. Synthesis and antitumor activity of nucleosides that have a hydroxylamino group instead of a hydroxyl group at the 2'- or 3'-position of the sugar moiety.
    Ogawa A; Tanaka M; Sasaki T; Matsuda A
    J Med Chem; 1998 Dec; 41(25):5094-107. PubMed ID: 9836625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug nanoparticles based on novel random copolymer containing cytarabine and fluorodeoxyuridine.
    Yin C; Li X; Wu Q; Wang JL; Lin XF
    J Colloid Interface Sci; 2010 Sep; 349(1):153-8. PubMed ID: 20621810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A photoactivated prodrug.
    Wei Y; Yan Y; Pei D; Gong B
    Bioorg Med Chem Lett; 1998 Sep; 8(18):2419-22. PubMed ID: 9873553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of nucleobase-modified analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd).
    Hrdlicka PJ; Jepsen JS; Nielsen C; Wengel J
    Bioorg Med Chem; 2005 Feb; 13(4):1249-60. PubMed ID: 15670934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic mechanisms of new antitumor nucleoside analogues, 3'-ethynylcytidine (ECyd) and 3'-ethynyluridine (EUrd).
    Kanda H; Takatori S; Matsuda A; Sasaki T; Tanaka M; Fukushima M; Wataya Y
    Nucleic Acids Symp Ser; 1997; (37):137-8. PubMed ID: 9586037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor mechanisms of 3'-ethynyluridine and 3'-ethynylcytidine as RNA synthesis inhibitors: development and characterization of 3'-ethynyluridine-resistant cells.
    Tabata S; Tanaka M; Endo Y; Obata T; Matsuda A; Sasaki T
    Cancer Lett; 1997 Jun; 116(2):225-31. PubMed ID: 9215867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and properties of 5-fluorouracil oligonucleotides.
    Koga M; Yasusa T; Yamamoto M; Haba S; Suzuki T; Saeki T; Ozaki S
    Nucleic Acids Symp Ser; 1995; (34):27-8. PubMed ID: 8841535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra and inter-molecular interactions dictate the aggregation state of irinotecan co-encapsulated with floxuridine inside liposomes.
    Dicko A; Frazier AA; Liboiron BD; Hinderliter A; Ellena JF; Xie X; Cho C; Weber T; Tardi PG; Cabral-Lilly D; Cafiso DS; Mayer LD
    Pharm Res; 2008 Jul; 25(7):1702-13. PubMed ID: 18320294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.